Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.4900 (-2.84%) ($6.2900 - $6.7200) on Tue. Aug. 18, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.46% (three month average) | RSI | 34 | Latest Price | $6.4900(-2.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -11.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) TLT(26%) IGOV(25%) VCIT(20%) TIP(16%) LQD(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.23% in a week (0% probabilities). URA(-36%) XLB(-33%) PAVE(-27%) XOP(-25%) OIH(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.23% (StdDev 8.46%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $7.29 | 5 Day Moving Average | $6.3(3.02%) | 10 Day Moving Average | $6.66(-2.55%) | 20 Day Moving Average | $7.29(-10.97%) | To recent high | -33.8% | To recent low | 29.5% | Market Cap | $128m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |